These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Protease-activated kinase II as the potential mediator of insulin-stimulated phosphorylation of ribosomal protein S6. Perisic O; Traugh JA J Biol Chem; 1983 Aug; 258(16):9589-92. PubMed ID: 6350281 [TBL] [Abstract][Full Text] [Related]
24. N-linked oligosaccharide chains of the insulin receptor beta subunit are essential for transmembrane signaling. Leconte I; Auzan C; Debant A; Rossi B; Clauser E J Biol Chem; 1992 Aug; 267(24):17415-23. PubMed ID: 1324936 [TBL] [Abstract][Full Text] [Related]
25. Evidence for insulin-dependent activation of S6 and microtubule-associated protein-2 kinases via a human insulin receptor/v-ros hybrid. Boulton TG; Gregory JS; Jong SM; Wang LH; Ellis L; Cobb MH J Biol Chem; 1990 Feb; 265(5):2713-9. PubMed ID: 2154457 [TBL] [Abstract][Full Text] [Related]
26. Intracellular signaling by a mutant human insulin receptor lacking the carboxyl-terminal tyrosine autophosphorylation sites. Takata Y; Webster NJ; Olefsky JM J Biol Chem; 1992 May; 267(13):9065-70. PubMed ID: 1577744 [TBL] [Abstract][Full Text] [Related]
27. Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues. Tobe K; Kadowaki T; Tamemoto H; Ueki K; Hara K; Koshio O; Momomura K; Gotoh Y; Nishida E; Akanuma Y J Biol Chem; 1991 Dec; 266(36):24793-803. PubMed ID: 1662217 [TBL] [Abstract][Full Text] [Related]
28. Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities. Wilden PA; Broadway DE J Cell Physiol; 1995 Apr; 163(1):9-18. PubMed ID: 7896903 [TBL] [Abstract][Full Text] [Related]
30. Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation. Maegawa H; Olefsky JM; Thies S; Boyd D; Ullrich A; McClain DA J Biol Chem; 1988 Sep; 263(25):12629-37. PubMed ID: 2970462 [TBL] [Abstract][Full Text] [Related]
31. Differential activation of mitogen-activated protein kinase and S6 kinase signaling pathways by 12-O-tetradecanoylphorbol-13-acetate (TPA) and insulin. Evidence for involvement of a TPA-stimulated protein-tyrosine kinase. Seger R; Biener Y; Feinstein R; Hanoch T; Gazit A; Zick Y J Biol Chem; 1995 Nov; 270(47):28325-30. PubMed ID: 7499332 [TBL] [Abstract][Full Text] [Related]
32. Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Lewis RE; Cao L; Perregaux D; Czech MP Biochemistry; 1990 Feb; 29(7):1807-13. PubMed ID: 2110001 [TBL] [Abstract][Full Text] [Related]
33. An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. Mukhopadhyay NK; Price DJ; Kyriakis JM; Pelech S; Sanghera J; Avruch J J Biol Chem; 1992 Feb; 267(5):3325-35. PubMed ID: 1737788 [TBL] [Abstract][Full Text] [Related]
34. Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Kellerer M; Lammers R; Ermel B; Tippmer S; Vogt B; Obermaier-Kusser B; Ullrich A; Häring HU Biochemistry; 1992 May; 31(19):4588-96. PubMed ID: 1374639 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the insulin receptor kinase by hyperinsulinism. Treadway JL; Whittaker J; Pessin JE J Biol Chem; 1989 Sep; 264(25):15136-43. PubMed ID: 2504716 [TBL] [Abstract][Full Text] [Related]
36. Assessment of the in situ tyrosine kinase activity of mutant insulin receptors lacking tyrosine autophosphorylation sites 1162 and 1163. Yonezawa K; Roth RA Mol Endocrinol; 1991 Feb; 5(2):194-200. PubMed ID: 1710030 [TBL] [Abstract][Full Text] [Related]
37. Decreased phosphorylation of mutant insulin receptor by protein kinase C and protein kinase A. Miele C; Formisano P; Sohn KJ; Caruso M; Pianese M; Palumbo G; Beguino L; Beguinot F J Biol Chem; 1995 Jun; 270(26):15844-52. PubMed ID: 7797589 [TBL] [Abstract][Full Text] [Related]
38. Use of an anti-insulin receptor antibody to discriminate between metabolic and mitogenic effects of insulin: correlation with receptor autophosphorylation. Ponzio G; Contreres JO; Debant A; Baron V; Gautier N; Dolais-Kitabgi J; Rossi B EMBO J; 1988 Dec; 7(13):4111-7. PubMed ID: 3072194 [TBL] [Abstract][Full Text] [Related]
39. Identical Mr 70,000 S6 kinase is activated biphasically by epidermal growth factor: a phosphopeptide that characterizes the late phase. Susa M; Thomas G Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7040-4. PubMed ID: 2402489 [TBL] [Abstract][Full Text] [Related]
40. Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action. Cama A; Quon MJ; de la Luz Sierra M; Taylor SI J Biol Chem; 1992 Apr; 267(12):8383-9. PubMed ID: 1314826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]